Current
16.6×
5-Year Average
12.0×
All-Time High
4481.3×
All-Time Low
4.7×
P/FCF Ratio daily chart for CVS Health (CVS)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
Historical P/FCF Ratio for CVS Health (CVS) from 2001 to 2025
| 2025 | $100.79B | $7.81B | 12.9× | +4.0× | |
| 2024 | $56.52B | $6.33B | 8.9× | -0.8× | |
| 2023 | $101.70B | $10.39B | 9.8× | +0.7× | |
| 2022 | $122.08B | $13.45B | 9.1× | +0.4× | |
| 2021 | $136.38B | $15.74B | 8.7× | +2.0× | |
| 2020 | $89.54B | $13.43B | 6.7× | -2.6× | |
| 2019 | $96.80B | $10.39B | 9.3× | -1.4× | |
| 2018 | $73.10B | $6.83B | 10.7× | -1.4× | |
| 2017 | $73.52B | $6.09B | 12.1× | +1.5× | |
| 2016 | $83.96B | $7.92B | 10.6× | -7.3× | |
| 2015 | $108.23B | $6.04B | 17.9× | -0.2× | |
| 2014 | $108.64B | $6.00B | 18.1× | -4.4× | |
| 2013 | $85.31B | $3.80B | 22.5× | +9.5× | |
| 2012 | $60.00B | $4.64B | 12.9× | -0.4× | |
| 2011 | $52.97B | $3.98B | 13.3× | -3.8× | |
| 2010 | $47.36B | $2.77B | 17.1× | -13.0× | |
| 2009 | $44.64B | $1.49B | 30.0× | +6.6× | |
| 2008 | $41.35B | $1.77B | 23.4× | -16.8× | |
| 2007 | $57.27B | $1.42B | 40.2× | — | |
| 2006 | $25.49B | −$26.50M | — | — | |
| 2005 | $21.52B | $116.70M | 184.4× | — | |
| 2004 | $18.36B | −$433.50M | — | — | |
| 2003 | $14.85B | −$152.80M | — | — | |
| 2002 | $9.81B | $96.00M | 102.2× | — | |
| 2001 | $11.39B | −$33.00M | — | — |
- 202512.9×
- 20248.9×
- 20239.8×
- 20229.1×
- 20218.7×
- 20206.7×
- 20199.3×
- 201810.7×
- 201712.1×
- 201610.6×
- 201517.9×
- 201418.1×
- 201322.5×
- 201212.9×
- 201113.3×
- 201017.1×
- 200930.0×
- 200823.4×
- 200740.2×
- 2006—
- 2005184.4×
- 2004—
- 2003—
- 2002102.2×
- 2001—
About P/FCF Ratio at CVS Health (CVS)
CVS Health (CVS) P/FCF ratio is 16.6× as of June 5, 2026. The 5-year average is 12.0×. The sector median currently stands at 19.8×. The current ratio is at the 89th percentile of its own 10-year history.
CVS Health (CVS) historical P/FCF ratio has ranged from a low of 4.7× (2023) to a high of 4481.3× (2004) in the available daily series.
The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.
CVS Health P/FCF Ratio by Year
CVS Health P/FCF Ratio 2025: 12.9×
CVS Health (CVS) P/FCF ratio in 2025 was 12.9×, expanded from 8.9× the prior year.
CVS Health P/FCF Ratio 2024: 8.9×
CVS Health (CVS) P/FCF ratio in 2024 was 8.9×, contracted from 9.8× the prior year.
CVS Health P/FCF Ratio 2023: 9.8×
CVS Health (CVS) P/FCF ratio in 2023 was 9.8×, expanded from 9.1× the prior year.
CVS Health P/FCF Ratio 2022: 9.1×
CVS Health (CVS) P/FCF ratio in 2022 was 9.1×, expanded from 8.7× the prior year.
CVS Health P/FCF Ratio 2021: 8.7×
CVS Health (CVS) P/FCF ratio in 2021 was 8.7×.
Sector peers by P/FCF Ratio — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by P/FCF Ratio — table
Healthcare peers of CVS Health (CVS), ranked by P/FCF ratio.
| 18.5× | |
| 17.8× | |
| 17.8× | |
| 16.9× | |
| 16.9× | |
| 16.7× | |
| 16.4× | |
| 16.3× | |
| 15.9× | |
| 14.0× | |
| 13.5× | |
| 12.9× | |
| 12.5× | |
| 12.2× | |
| 12.1× | |
| 11.3× | |
| 10.7× | |
| 10.4× | |
| 10.3× | |
| 10.0× | |
| 9.6× | |
| 9.1× | |
| 9.1× | |
| 6.9× | |
| 2.5× |
- 18.5×
- 17.8×
- 16.9×
- 16.7×
- 16.4×
- 13.5×
- 12.9×
- 10.7×
- 10.3×
- 9.1×
- 9.1×
- 6.9×
- 2.5×
Frequently asked questions
CVS Health (CVS) Key Financials
Charts, filings, and peer comparison for every metric